The MHA Keystone Center, a recognized healthcare organization, is set to launch an infection control quality improvement cohort. The initiative will provide comprehensive technical assistance to a group of ten selected long-term care (LTC) facilities. This project, named 'Strengthening Long-term Care Infection Prevention and Control Practices to Address Emerging Pathogens', aims to bolster existing infection…
Candida auris, an emerging yeast species and potential infection source, is garnering significant attention in the medical realm due to its multi-drug resistance and tendency for colonization and transmission. This opens up the potential for outbreaks within medical institutions. This analysis shines a light on the first recorded case of C. auris in a pediatric…
A recently published study in the American Journal of Infection Control advocates for health care facilities to initiate or increase admission screening for Candida auris based on community prevalence rates. This recommendation comes from a team led by Aaron Cheng, MPH, from Mount Sinai Beth Israel in New York City. Their study explores the potential…
A pioneering stride has been accomplished by researchers at Mount Sinai in the fight against the perilous fungal pathogen Candida auris. The New York City-based team has refined hospital screening methods, aiming to prevent the spread of difficult-to-eradicate fungal infections within medical facilities. Candida auris, which first emerged in 2016 in New York City, poses…
Understanding Mortality Factors in Candida Auris Bloodstream Infection: A Multicenter Study Analysis
A multicenter study has shed light on various factors that contribute to increased mortality among patients suffering from Candida auris bloodstream infection (BSI). The research, published in Clinical Infectious Diseases, suggests that a one-point rise in the Pitt bacteremia score (used to gauge the seriousness of a patient's acute illness) at the onset of C.…
Memorial Hermann Hospital, with locations in Houston, Texas and Texas Medical Center, has effectively curtailed the spread of the notorious and emergent multidrug-resistant fungus, Candida auris (C auris), by implementing an innovative and targeted isolation and screening protocol. This strategic approach shows promise in enhancing patient safety by minimizing exposure to healthcare-associated infections. C auris…
Despite being a common yeast that resides on the human body, Candida auris (C. auris) poses a major threat to individuals with weakened immune systems undergoing advanced treatments in medical facilities. This description corresponds to the assessment of Dr. Mark Rupp, Chief of the Division of Infectious Diseases at the University of Nebraska Medical Center.…
Recent updates from the healthcare sector in Seattle have confirmed a fourth case of the fungal infection, Candida auris (C. auris), at the Kindred Hospital Seattle. This follows the initial case which was detected on January 10, subsequent to which two more cases were discovered on January 22 among patients who had initially tested negative…